socalTECH

OCTOBER 23, 2019

Thousand Oaks-based biotech giant Amgen said today that its CFO, David W. Meline, is planning to retire, serving as CFO through the end of 2019, but will remain at the company through the second quarter of 2020. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Equity Develop Development 100

socalTECH

OCTOBER 22, 2014

Thousand Oaks-based biotech giant Amgen is a target of activist investor group Third Point , urging the company yesterday to split the company in two. amgen third point activist investors merger acquisition split private equity thirdpoint' READ MORE>>.

Thousand Oaks 147

Thousand Oaks Equity Acquisition Activity 147

socalTECH

APRIL 20, 2017

Thousand Oaks-based wireless networking equipment maker Xirrus has been acquired by Riverbed , to help bolster its SD WAN efforts, the two said on Wednesday. The company had counted Microsoft, University of Mississippi, Liverpool Football Club and Paul Hastings Law Firm as major customers.

Thousand Oaks 127

Thousand Oaks Acquisition Startup Networking 127

socalTECH

JANUARY 27, 2020

Kobe Bryant , the basketball legend who also was one half of Los Angeles private equity investment firm Bryant Stibel , is dead at the age of 41, after a tragic helicopter crash in Calabasas took his life, the life of one of his daughters, and seven others. READ MORE>>.

Thousand Oaks 113

Thousand Oaks Legalzoom Calabasas High Tech 113

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group.

Thousand Oaks 164

Thousand Oaks UCLA Venture Capital Equity 164

socalTECH

SEPTEMBER 8, 2011

Thousand Oaks-based biotech giant Amgen has backed a developer of therapeutic antibodies, via its venture capital arm, Amgen Ventures. According to Seattle-based Theraclone Sciences , Amgen Ventures was one of the investors in a $10.6M, Series B extension round for the company. READ MORE>>.

Thousand Oaks 150

Thousand Oaks Venture Capital Equity Capital 150

socalTECH

MAY 20, 2010

Thousand Oaks-based Ceres , a developer of biofuel crop technology, and Novozymes , a developer of enzymes, said today that the two have entered into a research collaboration around cellulosic biofuel production. Ceres is working on both crops to optimize the amount of sugar which can be used to produce biofuel. READ MORE>>.

Thousand Oaks 145

Thousand Oaks Equity Research Product 145